SYNTHOS RESEARCH

Starbucks SBUX

Consumer Cyclical · Restaurants · Synthos Deep Dive · 2026-07-03

$104.27
Hold
Risk 6Growth 4Exponential 3Fair value $100 $72–$132

At a glance

VerdictHold — systematic Synthos tier
Price (2026-07-02)$104.27 · market cap ~$118.8B
Synthos scores (0–10)Downside Risk 6 · Growth Quality 4 · Exponential Potential 3
Synthos fair value (base case)~$100−4% · full range $72 (bear) – $132 (bull)
Street consensus$108.5 (high $120 / low $90; 28 Buy · 28 Hold · 3 Sell) — context, not our anchor
Valuation79× trailing EPS · 44× FY26E · 34× FY27E · 21× FY30E · EV/S 3.7× · EV/EBITDA 26×
Exponential Potential3/10 · Low — a mature ~34k-store cafe chain; the story is margin recovery, not accelerating growth
TechnicalsUptrend — $104, −2.4% off 52-wk high, above 50/200-DMA, RSI 57, but only +9.9% 12-mo vs SPY +20.6% / QQQ +30.3%
ConvictionNone — 0 expert voices, 0 traceable claims in the Synthos KB; verdict rests on fundamentals + quant
Position sizingNot a flagship buy today; 0% / watch-list until margin recovery is proven
Next catalyst2026-08-04 Q4'26 earnings (Street EPS $0.65)
Single biggest riskThe "Back to Starbucks" turnaround stalls and trough earnings don't recover into the 79× multiple

One-line thesis. Starbucks is a great brand mid-restructuring: revenue is flat-to-slightly-up, margins and EPS have collapsed (FY25 EPS $1.63 vs $3.31 in FY24) under CEO Brian Niccol's costly "Back to Starbucks" turnaround, yet the stock trades at ~79× trailing and pays a dividend its free cash flow no longer covers — a recovery you must believe in to own here, so we say Watch, not Buy.

◆ Synthos call — Hold SBUX is a solid business largely reflected at ~$100 — fine to keep, no reason to chase; it gets interesting again below ~$85.
Downside Risk (lower = safer)
6/10 · High
79× trailing on trough earnings, net-debt/EBITDA 4.3× (incl. leases), dividend > FCF — but beta ~1 and a defensive brand.
Growth Quality
4/10 · Moderate
~5% forward revenue CAGR, EPS recovering off a depressed FY25 base, margins compressed mid-turnaround; moat intact but mature.
Exponential Potential
3/10 · Low
Mature global cafe chain, ~34k stores; recovery not acceleration, so no multibagger runway from a $119B cap.
⚖ Reverse-DCF cross-check Market-implied growth ≈ 30%/yr To justify today’s $104, earnings would have to compound roughly 30% a year for 10 years (9% discount rate). Analysts forecast ~5%/yr, so the market is pricing in MORE than what the Street expects.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

In plain English

Starbucks is the coffee chain you already know — roughly 34,000 stores worldwide. The business is not shrinking, but its profits fell sharply: the company earned about $1.63 per share last year, down from $3.31 the year before, because the new CEO is spending heavily to fix long lines, slow service, and a tired menu (the "Back to Starbucks" plan).

The problem for the stock: even with profits depressed, the shares are expensive — you're paying about $79 for every $1 of last year's earnings. That price only makes sense if profits bounce back strongly. They might, but it isn't proven yet. On top of that, the company pays a big dividend that last year cost more cash than the business generated — sustainable for now given the brand, but a yellow flag.

Our verdict is Watch: a wonderful brand, but wait for evidence the turnaround is actually lifting profits before paying up.

Here's what our three scores mean in everyday terms:

The one big worry: the turnaround fails to restore profit margins, and the stock's high price has no earnings to grow into.


Price & moving averages 12 months · 50 & 200-day averages · 52-week range

768493101109Jul '25Sep '25Nov '25Feb '26Apr '26Jul '2652w hi $107Price 10450-DMA 102200-DMA 9352w lo $78

Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

758594104114Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26Price 10420-day avg 101

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

705030Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26RSI 58.2

Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 58.

MACD 12 / 26 / 9 · trend & momentum

0Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26MACD 0.9signal 0.4

Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLY (sector)), set to 100 a year ago

8092103114126Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26S&P 500 120SBUX 111XLY (sector) 106

Solid = SBUX · dashed = S&P 500 · dotted = XLY (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

013274054$37BFY23EPS $4$36BFY24EPS $3$37BFY25EPS $2$38BFY26EEPS $2$39BFY27EEPS $3$41BFY28EEPS $4$44BFY29EEPS $4$47BFY30EEPS $5

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$104.27
Market cap$119B
P/E trailing
P/E FY26E / FY27E44× / 34×
EV / Sales3.7×
EV / EBITDA26.4×
Gross margin20.4%
Net margin3.9%
Dividend yield2.37%
Beta0.977
52-wk range$78 – $107
RSI(14)57
50 / 200-DMA$102 / $93
12-mo return+10% (SPY +21%)
Street target$108 ($90–$120)
Analyst grades28 Buy · 28 Hold · 3 Sell
FMP ratingC
Next earnings2026-08-05

What the experts actually said 0 traceable claims on SBUX · showing the highest-conviction voices

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

1. What it is

Starbucks Corporation (NASDAQ: SBUX) is the world's largest specialty-coffee retailer, founded in 1971 and headquartered in Seattle. It operates and licenses roughly 34,000 stores globally across three reporting segments — North America, International, and Channel Development (packaged/ready-to-drink through grocery and foodservice). Brands include Starbucks, Starbucks Reserve, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, and Princi. CEO Brian R. Niccol (formerly of Chipotle) took the helm in 2024 and launched the "Back to Starbucks" operational reset. Fiscal year ends late September.

Revenue mix (FY2025, from filings):

The strategic story today is a margin turnaround, not a growth story: fix throughput and staffing in US cafes, simplify the menu, rebuild the "third place" experience, and resolve the China question — all while revenue grows only low-single-digits.

2. The expert thesis — why the panel is bullish (traceable)

There is no expert coverage of Starbucks in the Synthos knowledge base. total_claims = 0, net_bullish_voices = 0, and the top list is empty. We will not manufacture conviction we don't have: no claim_id is cited anywhere in this note because none exists.

That absence is itself information. SBUX is in this queue because it is a Nasdaq-100 index member, not because a high-skill voice flagged it. Accordingly, this verdict is entirely fundamentals- and quant-driven — built from FMP financials, analyst consensus estimates, and our own scenario model — and should be read as lower-conviction than a name carrying a broad, reconciled expert panel. If and when expert claims enter the KB, this note will be re-scored.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

Score0–10The read
Downside Risk (lower = safer)6 · Elevated79× trailing on trough EPS, net-debt/EBITDA 4.3× (incl. ~$10.5B capital leases), negative book equity, and a dividend that exceeded FY25 FCF ($2.77B paid vs $2.44B FCF). Offsets: beta ~1.0, defensive consumer brand, investment-grade access.
Growth Quality4 · Below AverageRevenue CAGR only ~5% FY25→FY30E; EPS is recovering off a depressed base rather than compounding from strength; margins compressed mid-turnaround (net 3.9% TTM vs ~11% historically). Moat is real but the business is mature.
Exponential Potential3 · LowA ~34k-store global chain at a $119B cap. The bull case is reversion (margins back toward historical), not acceleration into a large untapped TAM. No multibagger runway.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.

CaseKey assumptionsFair value
Bull"Back to Starbucks" works: US comps re-accelerate, margins recover faster than consensus, China resolves favorably. FY27E EPS beats to ~$3.30 (vs $3.06 cons); market pays a recovery-premium ~40×.~$132 (+27%)
Base (our anchor)Turnaround progresses gradually — FY27E EPS ~$3.06 (consensus). A slow-growth, high-quality-brand compounder earns a ~33× forward multiple as EPS normalizes.~$100 (−4%)
BearTurnaround stalls, US traffic stays soft, China deteriorates or divestiture disappoints; margin recovery slips. FY27E EPS misses to ~$2.60; multiple de-rates to ~28×.~$72 (−31%)

Synthos fair value = the base case, ~$100 (−4%), with the full $72–$132 span as the honest range. Our base sits just below the current price and below the Street's $108.5 consensus — we are not paying up for an unproven margin recovery. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). SBUX is neither today — it is a mature franchise in a self-help recovery:

Exponential Potential: Low (3/10). Own SBUX, if at all, for a dividend + brand + margin-recovery thesis — not for exponential upside. An accelerating small-cap with these dynamics would score high; a mature mega-cap mid-turnaround does not.

5. Financials (real numbers — FMP annual/quarterly)

6. Valuation — priced in or room?

SBUX is not cheap on any near-term measure: 79× trailing EPS, 3.7× EV/sales, 26× EV/EBITDA. The trailing P/E is distorted upward because earnings are at a cyclical/turnaround trough — the forward path matters more. On live consensus, forward P/E compresses to 44× (FY26E $2.39) → 34× (FY27E $3.06) → 21× (FY30E $5.08) if the recovery lands. That's the entire bull case: you're paying up for EPS normalization. The FMP letter rating is "C" (overall score 2/5), flagging weak ROE, high leverage, and rich P/E — consistent with our read. Street targets (context): consensus $108.5, high $120, low $90 (28 Buy / 28 Hold / 3 Sell — a genuinely split Street). Our ~$100 base is below consensus because we decline to pre-pay for an unproven margin recovery. Not a value buy; a show-me at a full price.

7. Technicals (computed from the tech block)

8. Moat & competitive position

Starbucks' moat is a globally dominant consumer brand plus scale: ~34k stores, the leading loyalty program in the category, real estate density, and vertically-integrated roasting/supply. That brand is durable and the "third place" positioning still has pricing power. But the moat is mature and under pressure: US traffic softened into the turnaround; China faces intense low-price local competition (Luckin and others) and a strategic-stake review; and quick-service coffee is broadly competitive. The brand keeps SBUX defensive; it does not make it a grower.

Peer set (FMP-supplied, market cap): Chipotle $45B (Niccol's former shop, the turnaround template), Marriott $98B, Royal Caribbean $79B, Ferrari $68B, Nike $65B, O'Reilly $75B, Airbnb $88B, MercadoLibre $89B, Sea Ltd $63B, Carvana $75B. Note: this is FMP's broad consumer-cyclical peer list, not a clean cafe-chain comp set — the most instructive comparison is CMG, the operational-turnaround analog under the same CEO lineage.

9. Management, capital allocation & guidance

10. Catalysts & what to watch

Thesis tripwires (what would change the call): two more quarters without operating-margin improvement; US comps turning negative again; a dividend cut (would signal the balance sheet is tighter than it looks); or a value-destructive China outcome. Upside tripwire (toward Buy): clear, sustained margin recovery with US traffic inflecting positive.

11. Key risks

12. Verdict, position sizing & monitoring

Watch. Starbucks is a wonderful, defensive brand caught mid-turnaround, and CEO Niccol's playbook earns it the benefit of the doubt — but the numbers say wait. Earnings are at a trough (EPS $1.63 vs $3.31), the stock trades at ~79× trailing and ~34× FY27E, the dividend outran free cash flow last year, leverage is elevated, and the shares have lagged the market over 12 months. Our base-case fair value (~$100) sits slightly below today's price, so there is no margin of safety and no expert panel to raise conviction. This is a prove-it story: the right move is to watch for margin recovery, not to pay up ahead of it.


Provenance & disclosures